These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications. Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651 [TBL] [Abstract][Full Text] [Related]
5. A high number of IgG4-positive plasma cells rules out nodular lymphocyte predominant Hodgkin lymphoma. Kiil K; Bein J; Schuhmacher B; Thurner L; Schneider M; Hansmann ML; Hartmann S Virchows Arch; 2018 Dec; 473(6):759-764. PubMed ID: 30259184 [TBL] [Abstract][Full Text] [Related]
6. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology. Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658 [TBL] [Abstract][Full Text] [Related]
7. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only. van Grotel M; Lam KH; de Man R; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260 [TBL] [Abstract][Full Text] [Related]
8. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma]. Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003 [TBL] [Abstract][Full Text] [Related]
10. Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres. Illés A; Simon Z; Tóth E; Rosta A; Miltényi Z; Molnár Z Pathol Oncol Res; 2008 Dec; 14(4):411-21. PubMed ID: 18431694 [TBL] [Abstract][Full Text] [Related]
11. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma? Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis. Gerber NK; Atoria CL; Elkin EB; Yahalom J Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756 [TBL] [Abstract][Full Text] [Related]
13. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Huang JZ; Weisenburger DD; Vose JM; Greiner TC; Aoun P; Chan WC; Lynch JC; Bierman PJ; Armitage JO Leuk Lymphoma; 2004 Aug; 45(8):1551-7. PubMed ID: 15370206 [TBL] [Abstract][Full Text] [Related]
14. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW). Lo AC; Major A; Super L; Appel B; Shankar A; Constine LS; Marks LJ; Kelly KM; Metzger ML; Buhtoiarov IN; Mauz-Körholz C; Costa ARS; Binkley MS; Flerlage J Leuk Lymphoma; 2022 Aug; 63(8):1997-2000. PubMed ID: 35357263 [No Abstract] [Full Text] [Related]
15. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type. Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718 [TBL] [Abstract][Full Text] [Related]
17. A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma. Strobbe L; Valke LL; Diets IJ; van den Brand M; Aben K; Raemaekers JM; Hebeda KM; van Krieken JH Ann Hematol; 2016 Feb; 95(3):417-23. PubMed ID: 26732883 [TBL] [Abstract][Full Text] [Related]
19. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations. Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348 [TBL] [Abstract][Full Text] [Related]
20. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network. Farrell K; McKay P; Leach M Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]